Alvotech And Teva Claim First US Golimumab Filing
FDA Submission For Limited-Competition Simponi Biosimilar Follows EMA Acceptance
Alvotech and Teva have celebrated a first in the US with the FDA’s acceptance of a filing for their partnered AVT05 golimumab biosimilar rival to Simponi and Simponi Aria.
